In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.
Denouncing the $557 billion industry as “horrible middlemen,” responsible for—and “rich as hell” from— America’s incomparably high prescription drug prices, Trump vowed to get rid of ...
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
I don’t feel bad for lawmakers very often. But trying to solve the national problem of high health care costs and accessibility from a state-level perspective is rough. And almost impossible.
I don’t feel bad for lawmakers very often. But trying to solve the national problem of high health care costs and ...
Even though some of these "middlemen" are supposed to obtain drugs at a lower price for their clients (ie, insurance companies, pharmacies, hospital systems, et cetera), some argue their fees can ...
Neil Breslin, who served 28 years as in the New York State Senate, is expected to continue as a resource for regulating the ...